title: The effect of dantrolene sodium in Very Long Chain Acyl-CoA Dehydrogenase Deficiency.
abstract: We present a patient, who experienced recurrent episodes of rhabdomyolysis. Her beneficial response to treatment with dantrolene sodium was previously reported. Adult onset Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency has been diagnosed only recently. In adults, VLCAD deficiency results in recurrent fasting-, exercise-, or infection-induced muscle stiffness, muscle pain and myoglobinuria caused by rhabdomyolysis. This case illustrates for the first time the beneficial effect of dantrolene in VLCAD deficiency. We discuss the therapeutic mechanism of dantrolene sodium and its possible role as additional treatment modality for patients with VLCAD deficiency.
authors.affiliation: Neuromuscular Center Nijmegen, Department of Neurology, 935 Radboud University Nijmegen Medical Center, P.O. Box 9101, the Netherlands. n.voermans@neuro.umcn.nl
authors.forename: N C
authors.initials: NC
authors.lastname: Voermans
authors.forename: P J
authors.initials: PJ
authors.lastname: Poels
authors.forename: L A
authors.initials: LA
authors.lastname: Kluijtmans
authors.forename: B G
authors.initials: BG
authors.lastname: van Engelen
mesh_terms: D044942:Acyl-CoA Dehydrogenase, Long-Chain / Q000172:deficiency*; D000368:Aged; D003620:Dantrolene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D012206:Rhabdomyolysis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D009125:Muscle Relaxants, Central; D044942:Acyl-CoA Dehydrogenase, Long-Chain; D003620:Dantrolene